Pesquisas alternativas:
cancer compared » cancer comparison (Expandir a Pesquisa)
bad company » a company (Expandir a Pesquisa), lncd company (Expandir a Pesquisa), good company (Expandir a Pesquisa)
company law » company a (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa)
nat camp » fat camp (Expandir a Pesquisa), a camp (Expandir a Pesquisa), ac camp (Expandir a Pesquisa)
j cancer » j canter (Expandir a Pesquisa), j cantero (Expandir a Pesquisa), j candel (Expandir a Pesquisa)
law node » law code (Expandir a Pesquisa), law note (Expandir a Pesquisa), low node (Expandir a Pesquisa)
camp ca » camp a (Expandir a Pesquisa), camp c (Expandir a Pesquisa), camp camp (Expandir a Pesquisa)
cancer compared » cancer comparison (Expandir a Pesquisa)
bad company » a company (Expandir a Pesquisa), lncd company (Expandir a Pesquisa), good company (Expandir a Pesquisa)
company law » company a (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa)
nat camp » fat camp (Expandir a Pesquisa), a camp (Expandir a Pesquisa), ac camp (Expandir a Pesquisa)
j cancer » j canter (Expandir a Pesquisa), j cantero (Expandir a Pesquisa), j candel (Expandir a Pesquisa)
law node » law code (Expandir a Pesquisa), law note (Expandir a Pesquisa), low node (Expandir a Pesquisa)
camp ca » camp a (Expandir a Pesquisa), camp c (Expandir a Pesquisa), camp camp (Expandir a Pesquisa)
1
Por Segawa, Y, Ueoka, H, Kiura, K, Kamei, H, Tabata, M, Sakae, K, Hiraki, Y, Kawahara, S, Eguchi, K, Hiraki, S, Harada for the Okayama Lung Cancer Study Group, Mine
Publicado em 2000
“... lung cancer (NSCLC). We conducted a phase II study of combined chemoradiotherapy to find a more...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“...A standardized mortality ratio of 1.49 for respiratory system cancer (42 observed deaths versus...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Heuson, J C, Engelsman, E, Blonk-Van Der Wijst, J, Maass, H, Drochmans, A, Michel, J, Nowakowski, H, Gorins, A
Publicado em 1975
“...A randomized clinical trial of nafoxidine, a non-steroidal oestrogen antagonist...”Publicado em 1975
Obter o texto integral
Obter o texto integral
Artigo
4
Por van Slooten, H. J., Bonsing, B. A., Hiller, A. J., Colbern, G. T., van Dierendonck, J. H., Cornelisse, C. J., Smith, H. S.
Publicado em 1995
“... compared with the cell line. Immunohistochemical and flow cytometrical detection of a number of hormone...”Publicado em 1995
Obter o texto integral
Obter o texto integral
Artigo
5
“... associations found here suggest a potentially important role for starch in protection against colorectal cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“...In a clinical investigation of postoperative survival after primary surgery for stomach cancer, 390...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... invasive breast cancer cells as compared with non-metastatic cells. Furthermore, DJ-1 promoted breast...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Thomson, A H, McGrane, J, Mathew, J, Palmer, J, Hilton, D A, Purvis, G, Jenkins, R
Publicado no Br J Cancer (2016)
“...BACKGROUND: Breast cancer commonly metastasises to the brain, but little is known about changes...”Publicado no Br J Cancer (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“..., but studies of the cancer incidence in larger groups of men with KS are lacking. A cohort of 696 men with KS...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Winters, H., Tielemans, H. J. P., Hameeteman, M., Paulus, V. A. A., Beurskens, C. H., Slater, N. J., Ulrich, D. J. O.
Publicado no Breast Cancer Res Treat (2017)
“...INTRODUCTION: Lymphedema can be a debilitating condition, causing a great decrease in a person’s...”Publicado no Breast Cancer Res Treat (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Marinelli, A., van de Velde, C. J., Kuppen, P. J., Franken, H. C., Souverijn, J. H., Eggermont, A. M.
Publicado em 1990
“...Systemic toxicity is usually the dose-limiting factor in cancer chemotherapy. Regional chemotherapy...”Publicado em 1990
Obter o texto integral
Obter o texto integral
Artigo
12
“...PURPOSE: Although much effort has focused on identifying national comparative effectiveness...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... occurring in the same individual of a general population was developed and was compared with the practical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Simes, R J, Tattersall, M H, Coates, A S, Raghavan, D, Solomon, H J, Smartt, H
Publicado em 1986
“... substantive information on the impact of these different practices on the patients. A randomised study...”Publicado em 1986
Obter o texto integral
Obter o texto integral
Artigo
15
Por Belinsky, S A, Grimes, M J, Casas, E, Stidley, C A, Franklin, W A, Bocklage, T J, Johnson, D H, Schiller, J H
Publicado em 2007
“... in primary lung cancer. A panel of eight genes was evaluated by comparing methylation detected in the primary...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“... cancer, noninfiltrating cancer, or infiltrating cancer less than 1 cm with negative nodes. The "high ridk...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“...A prospective randomised double blind crossover trial was conducted comparing the new synthetic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Brenkman, H. J. F., Ruurda, J. P., Verhoeven, R. H. A., van Hillegersberg, R.
Publicado no Gastric Cancer (2017)
“... had a comparable lymph node yield (OR, 1.01; 95% CI, 0.75–1.36), R0 resection rate (OR, 0.86; 95% CI...”Publicado no Gastric Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“...), but they confirm also a statistically significant excess of both lung and stomach cancer mortality. A small excess...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Huh, J H, Kim, T H, Kim, K, Song, J-A, Jung, Y J, Jeong, J-Y, Lee, M J, Kim, Y K, Lee, D H, An, H J
Publicado em 2013
“... SKpac sublines was compared with that of the PTX-sensitive, parental SKOV3 ovarian cancer cell line...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo